In summary, this study provides the first evidence that miR-148b-5p acts as a tumor suppressor miRNA, and that miR-148b-5p deficiency induces GC development and immune tolerance via the miR-148b-5p/ATPIF1/TNFa plus IL6 and CSF1 axis. This evidence concerns the gene IL6 and neoplasm.